Arginine

Arginine

SCHEMBL936448

N=C(N)NCCCC(N)C(=O)O.NC(CC(=O)O)C(=O)O.NCC(=O)O

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACES1PR1S1PR4S1PR5

The experimentally established mechanism targets of Arginine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OTC P00480 1/20 0.46
DDAH1 O94760 3/20 0.43
GSR P00390 2/20 0.42
NOS2 P35228 6/20 0.41
NOS3 P29474 5/20 0.41
NOS1 P29475 5/20 0.41
CYP1A2 P05177 3/20 0.38
CYP2C19 P33261 2/20 0.38
TSHR P16473 2/20 0.38
GLA P06280 1/20 0.38
NFKB1 P19838 1/20 0.38
APEX1 P27695 1/20 0.38
GRM8 O00222 1/20 0.37
GRM6 O15303 1/20 0.37
GRIN2D O15399 1/20 0.37
GRIN3B O60391 1/20 0.37
GRIK1 P39086 1/20 0.37
GRM5 P41594 1/20 0.37
GRIA1 P42261 1/20 0.37
GRIA2 P42262 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Arginine SCHEMBL4203993 1.00 OTC (0.46) OTCDDAH1GSRNOS2NOS3
Arginine SCHEMBL27889814 1.00 OTC (0.46) OTCDDAH1GSRNOS2NOS3
Arginine SCHEMBL4208039 1.00 OTC (0.46) OTCDDAH1GSRNOS2NOS3
Arginine SCHEMBL17550 1.00 OTC (0.46) OTCDDAH1GSRNOS2NOS3
Arginine SCHEMBL28160285 1.00 OTC (0.46) OTCDDAH1GSRNOS2NOS3
Arginine SCHEMBL5965923 1.00 OTC (0.46) OTCDDAH1GSRNOS2NOS3
Arginine SCHEMBL26623152 0.96 OTC (0.43) OTCDDAH1GSRNOS2NOS3
Aspartic Acid SCHEMBL2028617 0.96 GSR (0.45) OTCDDAH1GSRNOS2NOS3
Arginine SCHEMBL150228 0.95 OTC (0.49) OTCDDAH1GSRNOS2NOS3
Arginine SCHEMBL27692295 0.95 OTC (0.49) OTCDDAH1GSRNOS2NOS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 115 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103989624-B A kind of irinotecan hydrochloride composition and preparation method thereof 中国科学院上海药物研究所 2018-04-27 CN claimed
CN-107669632-A A kind of pharmaceutical carrier, micella, antitumor and antitumor cell diversion medicaments preparation, and its production and use 四川大学 2018-02-09 CN claimed
CN-106749517-A A kind of polysaccharide derivates containing polypeptide targeting factor and preparation method thereof 中山大学 2017-05-31 CN claimed
CN-105866206-A Method for in-situ and real-time detection of concentration of hydrogen peroxide in living cells 国家纳米科学中心 2016-08-17 CN claimed
CN-104784708-A NGR (asparagine-glycine-arginine)-PEG (polyethylene glycol)-QD (quantum dot) nano material and preparation method thereof CHENG YUAN 2015-07-22 CN claimed
CN-103212092-B Multifunctional coordination copolymer nanometer material as well preparation method and application thereof UNIV SHANGHAI 2014-09-17 CN claimed
CN-103989624-A Irinotecan hydrochloride composition and preparation method thereof SHANGHAI INST MATERIA MEDICA 2014-08-20 CN claimed
EP-2296580-A2 CORNEAL ONLAY DEVICES AND METHODS Forsight Labs, Llc (US) 2011-03-23 EP claimed
EP-2276420-A2 THERAPEUTIC DEVICE FOR PAIN MANAGEMENT AND VISION Forsight Labs, Llc (US) 2011-01-26 EP claimed
WO-2009145842-A9 THERAPEUTIC DEVICE FOR PAIN MANAGEMENT AND VISION FORSIGHT LABS, LLC (US) 2010-11-18 WO claimed
WO-2009146151-A2 CORNEAL ONLAY DEVICES AND METHODS FORSIGHT LABS, LLC (US) 2009-12-03 WO claimed
WO-2009145842-A2 THERAPEUTIC DEVICE FOR PAIN MANAGEMENT AND VISION FORSIGHT LABS, LLC (US) 2009-12-03 WO claimed
US-7470424-B2 Cultured cell construct containing spheroids of cultured animal cells and utilization thereof TRANSPARENT INC. (JP) 2008-12-30 US claimed
CN-101314641-A Aliphatic polyester series microspheres, preparation and application thereof CHINESE ACAD INST CHEMISTRY (CN) 2008-12-03 CN claimed
WO-2007146319-A9 METHODS AND APPARATUS FOR USING POLYMER-BASED BEADS AND HYDROGELS FOR CARDIAC APPLICATIONS SYMPHONY MEDICAL INC (US) 2008-04-24 WO claimed
WO-2007146319-A2 METHODS AND APPARATUS FOR USING POLYMER-BASED BEADS AND HYDROGELS FOR CARDIAC APPLICATIONS SYMPHONY MEDICAL, INC. (US) 2007-12-21 WO claimed
CN-1328289-C Endothelium chalone capable of improving antitumor activity with changed structure and its use UNIV HARBIN MEDICAL (CN) 2007-07-25 CN claimed
CN-1670035-A Endothelium chalone capable of improving antitumor activity with changed structure and its use UNIV HARBIN MEDICAL (CN) 2005-09-21 CN claimed
US-20250345273-A1 DEGRADABLE POLY(VINYL ALCOHOL) HYDROGELS FOR WOUND HEALING APPLICATIONS OFFICE OF TECHNOLOGY TRANSFER (US) 2025-11-13 US disclosed
US-5415636-A Dilation-drug delivery catheter SCHNEIDER (USA) INC (US) 1995-05-16 US disclosed